These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 19006606

  • 1. Pharmacology of proton pump inhibitors.
    Shin JM, Sachs G.
    Curr Gastroenterol Rep; 2008 Dec; 10(6):528-34. PubMed ID: 19006606
    [Abstract] [Full Text] [Related]

  • 2. Novel approaches to inhibition of gastric acid secretion.
    Sachs G, Shin JM, Hunt R.
    Curr Gastroenterol Rep; 2010 Dec; 12(6):437-47. PubMed ID: 20924727
    [Abstract] [Full Text] [Related]

  • 3. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G, Shin JM, Howden CW.
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.
    Ward RM, Kearns GL.
    Paediatr Drugs; 2013 Apr; 15(2):119-31. PubMed ID: 23512128
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE, Gold BD.
    Paediatr Drugs; 2003 Apr; 5(1):25-40. PubMed ID: 12513104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insights into the future of gastric acid suppression.
    DeVault KR, Talley NJ.
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):524-32. PubMed ID: 19713987
    [Abstract] [Full Text] [Related]

  • 11. Pantoprazole.
    Poole P.
    Am J Health Syst Pharm; 2001 Jun 01; 58(11):999-1008. PubMed ID: 11402494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K, Carlsson E.
    Pharmacol Ther; 2005 Dec 01; 108(3):294-307. PubMed ID: 16000224
    [Abstract] [Full Text] [Related]

  • 14. Proton pump inhibitors and acid-related diseases.
    Sachs G.
    Pharmacotherapy; 1997 Dec 01; 17(1):22-37. PubMed ID: 9017763
    [Abstract] [Full Text] [Related]

  • 15. The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.
    Scott DR, Munson KB, Marcus EA, Lambrecht NW, Sachs G.
    Aliment Pharmacol Ther; 2015 Dec 01; 42(11-12):1315-26. PubMed ID: 26423447
    [Abstract] [Full Text] [Related]

  • 16. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G, Shin JM, Vagin O, Lambrecht N, Yakubov I, Munson K.
    J Clin Gastroenterol; 2007 Jul 01; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [Abstract] [Full Text] [Related]

  • 17. Physiology of the parietal cell and therapeutic implications.
    Sachs G.
    Pharmacotherapy; 2003 Oct 01; 23(10 Pt 2):68S-73S. PubMed ID: 14587960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 01; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.